The molecular basis of hereditary palmoplantar keratodermas

Journal of the American Academy of Dermatology

Volumn 47, Issue 3, 2002, Pages 327-346

  Kimyai Asadi, Arash ^a   Kotcher, Lauren B ^a   Jih, Ming H ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CADHERIN; CATHEPSIN; CELL ADHESION MOLECULE; DESMOGLEIN; DESMOPLAKIN; DNA; ELAFIN; ENVOPLAKIN; FILAGGRIN; GAP JUNCTION PROTEIN; INVOLUCRIN; KERATIN; LORICRIN; PERIPLAKIN; PLAKOGLOBIN; PROFILAGGRIN; PROLINE; PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN S 100; PYROGLUTAMIC ACID; SERINE TRANSFER RNA; STEFIN A; TYROSINE AMINOTRANSFERASE; UROCANIC ACID;

CELL DIFFERENTIATION; DESMOSOME; DISEASE ASSOCIATION; EPIDERMIS; GENE; GENE MUTATION; HUMAN; IMMUNOELECTRON MICROSCOPY; KERATINOCYTE; KERATOSIS PALMOPLANTARIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; TYROSINEMIA;

ANIMALS; CONNEXINS; DESMOSOMES; HUMANS; KERATINS; KERATODERMA, PALMOPLANTAR; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; PROTEINS; TRANSGENES;

EID: 0036739220     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.124814     Document Type: Article

References (147)

1. Christiano AM. Frontiers in keratodermas: pushing the envelope. Trends Genet 1997;13:227-33.
2. Nemes Z, Steinert PM. Bricks and mortar of the epidermal barrier. Exp Mol Med 1999;31:5-19.
3. Steven AC, Bisher ME, Roop DR, Steinert PM. Biosynthetic pathways of filaggrin and loricrin-two major proteins expressed by terminally differentiated epidermal keratinocytes. J Struct Biol 1990;104:150-62.
4. Ishida-Yamamoto A, Tanaka H, Nakane H, Takahashi H, Hashimoto Y, Iizuka H. Programmed cell death in normal epidermis and loricrin keratoderma. Multiple functions of profilaggrin in keratinization. J Investig Dermatol Symp Proc 1999;4:145-9.
5. Scott IR, Harding CR. Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environment. Dev Biol 1986;115:84-92.
6. Morrison H. Photochemistry and photobiology of urocanic acid. Photodermatology 1985;2:158-65.
7. Ming ME, Daryanani HA, Roberts LP, Baden HP, Kvedar JC. Binding of keratin intermediate filaments (K10) to the cornified envelope in mouse epidermis: implications for barrier function. J Invest Dermatol 1994;103:780-4.
8. Steinert PM, Marekov LN. The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J Biol Chem 1995;270:17702-11.
9. Koch PJ, de Viragh PA, Scharer E, Bundman D, Longley MA, Bickenbach J, et al. Lessons from loricrin-deficient mice: compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein. J Cell Biol 2000;151: 389-400.
10. Mischke D, Korge BP, Marenholz I, Volz A, Ziegler A. Genes encoding structural proteins of epidermal cornification and 5100 calcium-binding proteins form a gene complex ("epidermal differentiation complex") on human chromosome 1q21. J Invest Dermatol 1996;106:989-92.
11. Volz A, Korge BP, Compton JG, Ziegler A, Steinert PM, Mischke D. Physical mapping of a functional cluster of epidermal differentiation genes on chromosome 1q21. Genomics 1993;18:92-99.
12. Maestrini E, Monaco AP, McGrath JA, Ishida-Yamamoto A, Camisa C, Hovnanian A, et al. A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel's syndrome. Nat Genet 1996;13:70-7.
13. Hohl D, Lichti U, Breitkreutz D, Steinert PM, Roop DR. Transcription of the human loricrin gene in vitro is induced by calcium and cell density and suppressed by retinoic acid. J Invest Dermatol 1991;96:414-8.
14. Yoneda K, Steinert PM. Overexpression of human loricrin in transgenic mice produces a normal phenotype. Proc Nat Acad Sci U S A 1993;90:10754-8.
15. Candi E, Tarcsa E, Idler WW, Kartasova T, Marekov LN, Steinert PM. Transglutaminase cross-linking properties of the small proline-rich 1 family of cornified cell envelope proteins. Integration with loricrin. J Biol Chem 1999;274:7226-37.
16. Candi E, Melino G, Mei G, Tarcsa E, Chung SI, Marekov LN, et al. Biochemical, structural, and transglutaminase substrate properties of human loricrin, the major epidermal cornified cell envelope protein. J Biol Chem 1995;270:26382-90.
17. Hohl D, Mehrel T, Lichti U, Turner ML, Roop DR, Steinert PM. Characterization of human loricrin. Structure and function of a new class of epidermal cell envelope proteins. J Biol Chem 1991; 266:6626-36.
18. Vohwinkel KH. Keratoma hereditarium mutilans. Arch Dermatol Syph 1929;158:354-64.
19. Korge BP, Ishida-Yamamoto A, Punter C, Dopping-Hepenstal PJ, lizuka H, Stephenson A, et al. Loricrin mutation in Vohwinkel's keratoderma is unique to the variant with ichthyosis. J Invest Dermatol 1997;109:604-10.
20. Ishida-Yamamoto A, Takahashi H, Iizuka H. Loricrin and human skin diseases: molecular basis of loricrin keratodermas. Histol Histopathol 1998;13:819-26.
21. Ishida-Yamamoto A, McGrath JA, Lam H, Iizuka H, Friedman RA, Christiano AM. The molecular pathology of progressive symmetric erythrokeratodermia: a frameshift mutation in the loricrin gene and perturbations in the cornified cell envelope. Am J Hum Genet 1997;61:581-9.
22. Suga Y, Jarnik M, Attar PS, Longley MA, Bundman D, Steven AC, et al. Transgenic mice expressing a mutant form of loricrin reveal the molecular basis of the skin diseases, Vohwinkel syndrome and progressive symmetric erythrokeratodermia. J Cell Biol 2000;151:401-12.
23. Ishida-Yamamoto A, Kato H, Kiyama H, Armstrong DK, Munro CS, Eady RA, et al. Mutant loricrin is not crosslinked into the cornified cell envelope but is translocated into the nucleus in loricrin keratoderma. J Invest Dermatol 2000;115:1088-94.
24. Ishida-Yamamoto A, Takahashi H, Presland RB, Dale BA, Iizuka H. Translocation of profilaggrin N-terminal domain into keratinocyte nuclei with fragmented DNA in normal human skin and loricrin keratoderma. Lab Invest 1998;78:1245-53.
25. Irvine AD, McLean WHI. Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation. Br J Dermatol 1999;140:815-28.
26. Rothnagel JA, Wojcik S, Liefer KM, Dominey AM, Huber M, Hohl D, et al. Mutations in the 1A domain of keratin 9 in patients with epidermolytic palmoplantar keratoderma. J Invest Dermatol 1995;104:430-3.
27. Navsaria HA, Swensson O, Ratnavel RC, Shamsher M, McLean WH, Lane EB, et al. Ultrastructural changes resulting from keratin-9 gene mutations in two families with epidermolytic palmoplantar keratoderma. J Invest Dermatol 1995;104:425-9.
28. Hashimoto K, Mizuguchi R, Tanaka K, Dorman M. Palmoplantar keratoderma (Voerner) with composite keratohyalin granules: studies on keratinization parameters and ultrastructures. J Dermatol 2000;27:1-9.
29. Reis A, Kuster W, Eckardt R, Sperling K. Mapping of a gene for epidermolytic palmoplantar keratoderma to the region of the acidic keratin gene cluster at 17q12-q21. Hum Genet 1992;90: 113-6.
30. Szalai S, Szalai C, Becker K, Torok E. Keratin 9 mutations in the coil 1A region in epidermolytic palmoplantar keratoderma. Pediatr Dermatol 1999;16:430-5.
31. Covello SP, Irvine AD, McKenna KE, Munro CS, Nevin NC, Smith FJ, et al. Mutations in keratin K9 in kindreds with epidermolytic palmoplantar keratoderma and epidemiology in Northern Ireland. J Invest Dermatol 1998;111:1207-9.
32. Morgan VA, Byron K, Paiman L, Varigos GA. A case of spontaneous mutation in the keratin 9 gene associated with epidermolytic palmoplantar keratoderma. Australas J Dermatol 1999;40: 215-6.
33. Bonifas JM, Matsumura K, Chen MA, Berth-Jones J, Hutchison PE, Zloczower M, et al. Mutations of keratin 9 in two families with palmoplantar epidermolytic hyperkeratosis. J Invest Dermatol 1994;103:474-7.
34. Torchard D, Blanchet-Bardon C, Serova O, Langbein L, Narod S, Janin N, et al. Epidermolytic palmoplantar keratoderma cosegregates with a keratin 9 mutation in a pedigree with breast and ovarian cancer. Nat Genet 1994;6:106-10.
35. Endo H, Hatamochi A, Shinkai H. A novel mutation of a leucine residue in coil 1A of keratin 9 in epidermolytic palmoplantar keratoderma. J Invest Dermatol 1997;109:113-5.
36. Hennies HC, Zehender D, Kunze J, Kuster W, Reis A. Keratin 9 gene mutational heterogeneity in patients with epidermolytic palmoplantar keratoderma. Hum Genet 1994;93:649-54.
37. Reis A, Hennies HC, Langbein L, Digweed M, Mischke D, Drechsler M, et al. Keratin 9 gene mutations in epidermolytic palmoplantar keratoderma (EPPK). Nat Genet 1994;6:174-9.
38. Yang JM, Lee S, Kang HJ, Lee JH, Yeo UC, Son IY, et al. Mutations in the 1A rod domain segment of the keratin 9 gene in epidermolytic palmoplantar keratoderma. Acta Derm Venereol 1998; 78:412-6.
39. Coleman CM, Munro CS, Smith FJ, Uitto J, McLean WH. Epidermolytic palmoplantar keratoderma due to a novel type of keratin mutation, a 3-bp insertion in the keratin 9 helix termination motif. Br J Dermatol 1999;140:486-90.
40. Hatsell SJ, Eady RA, Wennerstrand L, Dopping-Hepenstal P, Leigh IM, Munro C, et al. Novel splice site mutation in keratin 1 underlies mild epidermolytic palmoplantar keratoderma in three kindreds. J Invest Dermatol 2001;116:606-9.
41. Michael EJ, Schneiderman P, Grossman ME, Christiano AM. Epidermolytic hyperkeratosis with polycyclic psoriasiform plaques resulting from a mutation in the keratin 1 gene. Exp Dermatol 1999;8:501-3.
42. Sprecher E, Ishida-Yamamoto A, Becker OM, Marekov L, Miller CJ, Steinert PM, et al. Evidence for novel functions of the keratin tail emerging from a mutation causing ichthyosis hystrix. J Invest Dermatol 2001;116:511-9.
43. Kimonis V, DiGiovanna JJ, Yang JM, Doyle SZ, Bale SJ, Compton JG. A mutation in the V1 end domain of keratin 1 in non-epidermolytic palmar-plantar keratoderma. J Invest Dermatol 1994; 103:764-9.
44. Candi E, Tarcsa E, Digiovanna JJ, Compton JG, Elias PM, Marekov LN, et al. A highly conserved lysine residue on the head domain of type II keratins is essential for the attachment of keratin intermediate filaments to the cornified cell envelope through isopeptide crosslinking by transglutaminases. Proc Natl Acad Sci U S A 1998;95:2067-72.
45. DiGiovanna JJ, Bale SJ. Clinical heterogeneity in epidermolytic hyperkeratosis. Arch Dermatol 1994;130:1026-35.
46. McLean WH, Rugg EL, Lunny DP, Morley SM, Lane EB, Swensson O, et al. Keratin 16 and keratin 17 mutations cause pachyonychia congenita. Nat Genet 1995;9:273-8.
47. Bowden PE, Haley JL, Kansky A, Rothnagel JA, Jones DO, Turner RJ. Mutation of a type II keratin gene (K6a) in pachyonychia congenita. Nat Genet 1995;10:363-5.
48. Smith FJ, Corden LD, Rugg EL, Ratnavel R, Leigh IM, Moss C, et al. Missense mutations in keratin 17 cause either pachyonychia congenita type 2 or a phenotype resembling steatocystoma multiplex. J Invest Dermatol 1997;108:220-3.
49. Shamsher MK, Navsaria HA, Stevens HP, Ratnavel RC, Purkis PE, Kelsell DP, et al. Novel mutations in keratin 16 gene underly focal non-epidermolytic palmoplantar keratoderma (NEPPK) in two families. Hum Mol Genet 1995;4:1875-81.
50. Smith FJ, Fisher MP, Healy E, Rees JL, Bonifas JM, Epstein EH Jr, et al. Novel keratin 16 mutations and protein statement studies in pachyonychia congenita type 1 and focal palmoplantar keratoderma. Exp Dermatol 2000;9:170-7.
51. Sasaki Y, Shimizu H, Akiyama M, Yoneda K, Ishida-Yamamoto A, Watanabe S, et al. Abnormalities of basal cell keratin in epidermolysis bullosa simplex do not affect the statement patterns of suprabasal keratins and cornified cell envelope proteins. Arch Dermatol Res 1998;290:591-7.
52. Livingston RJ, Sybert VP, Smith LT, Dale BA, Presland RB, Stephens K. Expression of a truncated keratin 5 may contribute to severe palmar-plantar hyperkeratosis in epidermolysis bullosa simplex patients. J Invest Dermatol 2001;116:970-4.
53. Shemanko CS, Mellerio JE, Tidman MJ, Lane EB, Eady RA. Severe palmo-plantar hyperkeratosis in Dowling-Meara epidermolysis bullosa simplex caused by a mutation in the keratin 14 gene (KRT14). J Invest Dermatol 1998;111:893-5.
54. Porter RM, Leitgeb S, Melton DW, Swensson O, Eady RA, Magin TM. Gene targeting at the mouse cytokeratin 10 locus: severe skin fragility and changes of cytokeratin statement in the epidermis. J Cell Biol 1996;132:925-36.
55. Reichelt J, Bauer C, Porter R, Lane E, Magin V. Out of balance: consequences of a partial keratin 10 knockout. J Cell Sci 1997;110:2175-86.
56. Wojcik SM, Bundman DS, Roop DR. Delayed wound healing in keratin 6a knockout mice. Mol Cell Biol 2000;20:5248-55.
57. Wong P, Colucci-Guyon E, Takahashi K, Gu C, Babinet C, Coulombe PA. Introducing a null mutation in the mouse K6alpha and K6beta genes reveals their essential structural role in the oral mucosa. J Cell Biol 2000;150:921-8.
58. Troy TC, Turksen K. In vitro characteristics of early epidermal progenitors isolated from keratin 14 (K14)-deficient mice: insights into the role of keratin 17 in mouse keratinocytes. J Cell Physiol 1999;180:409-21.
59. Peters B, Kirfel J, Bussow H, Vidal M, Magin TM. Complete cytolysis and neonatal lethality in keratin 5 knockout mice reveal its fundamental role in skin integrity and in epidermolysis bullosa simplex. Mol Biol Cell 2001;12:1775-89.
60. Chan Y, Anton-Lamprecht I, Yu QC, Jackel A, Zabel B, Ernst JP, et al. A human keratin 14 "knockout": the absence of K14 leads to severe epidermolysis bullosa simplex and a function for an intermediate filament protein. Genes Dev 1994;8:2574-87.
61. Rugg EL, McLean WH, Lane EB, Pitera R, McMillan JR, Dopping-Hepenstal PJ, et al. A functional "knockout" of human keratin 14. Genes Dev 1994;8:2563-73.
62. Batta K, Rugg EL, Wilson NJ, West N, Goodyear H, Lane EB, et al. A keratin 14 'knockout' mutation in recessive epidermolysis bullosa simplex resulting in less severe disease. Br J Dermatol 2000;143:621-7.
63. Kobayashi S, Tanaka T, Matsuyoshi N, Imamura S. Keratin 9 point mutation in the pedigree of epidermolytic hereditary palmoplantar keratoderma perturbs keratin intermediate filament network formation. FEBS Lett 1996;386:149-55.
64. Swensson O, Eady RA. Morphology of the keratin filament network in palm and sole skin: evidence for site-dependent features based on stereological analysis. Arch Dermatol Res 1996; 288:55-62.
65. Lane EB, Rugg EL, Navsaria H, Leigh IM, Heagerty AH, Ishida-Yamamoto A, et al. A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering. Nature 1992;356:244-6.
66. Sprecher E, Ishida-Yamamoto A, Becker OM, Marekov L, Miller CJ, Steinert PM, et al. Evidence for novel functions of the keratin tail emerging from a mutation causing ichthyosis hystrix. J Invest Dermatol 2001;116:511-9.
67. Robinson NA, Lapic S, Welter JF, Eckert RL. S100A11, S100A10, annexin I, desmosomal proteins, small proline-rich proteins, plasminogen activator inhibitor-2, and involucrin are components of the cornified envelope of cultured human epidermal keratinocytes. J Biol Chem 1997;272:12035-46.
68. Green KJ, Parry DA, Steinert PM, Virata ML, Wagner RM, Angst BD, et al. Structure of the human desmoplakins. Implications for function in the desmosomal plaque. J Biol Chem 1990;265:2603- 12.
69. Cserhalmi-Friedman PB, Frank JA, Ahmad W, Panteleyev AA, Aita VM, Christiano AM. Structural analysis reflects the evolutionary relationship between the human desmocollin gene family members. Exp Dermatol 2001;10:95-9.
70. Anhalt GJ. Making sense of antigens and antibodies in pemphigus. J Am Acad Dermatol 1999;40:763-6.
71. Ishii M, Izumi J, Fujiwara H, Ito M, Hamada M. Immunoblotting detection of gamma-catenin (plakoglobin) antibody in the serum of a patient with paraneoplastic pemphigus. Br J Dermatol 2001;144:377-9.
72. Amagai M, Nishikawa T, Nousari HC, Anhalt GJ, Hashimoto T. Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice. J Clin Invest 1998;102:775-82.
73. Hennies HC, Kuster W, Mischke D, Reis A. Localization of a locus for the striated form of palmoplantar keratoderma to chromosome 18q near the desmosomal cadherin gene cluster. Hum Mol Genet 1995;4:1015-20.
74. Rickman L, Simrak D, Stevens HP, Hunt DM, King IA, Bryant SP, et al. N-terminal deletion in a desmosomal cadherin causes the autosomal dominant skin disease striate palmoplantar keratoderma. Hum Mol Genet 1999;8:971-6.
75. Armstrong DK, McKenna KE, Purkis PE, Green KJ, Eady RA, Leigh IM, et al. Haploinsufficiency of desmoplakin causes a striate subtype of palmoplantar keratoderma. Hum Mol Genet 1999;8:143-8.
76. Norgett EE, Hatsell SJ, Carvajal-Huerta L, Cabezas JC, Common J, Purkis PE, et al. Recessive mutation in desmoplakin disrupts desmoplakin-intermediate filament interactions and causes dilated cardiomyopathy, woolly hair and keratoderma. Hum Mol Genet 2000;9:2761-6.
77. Gallicano GI, Kouklis P, Bauer C, Yin M, Vasioukhin V, Degenstein L, et al. Desmoplakin is required early in development for assembly of desmosomes and cytoskeletal linkage. J Cell Biol 1998; 143:2009-22.
78. Protonotarios N, Tsatsopoulou A, Fontaine G. Naxos disease: keratoderma, scalp modifications, and cardiomyopathy. J Am Acad Dermatol 2001;44:309-11.
79. Coonar AS, Protonotarios N, Tsatsopoulou A, Needham EW, Houlston RS, Cliff S, et al. Gene for arrhythmogenic right ventricular cardiomyopathy with diffuse nonepidermolytic palmoplantar keratoderma and woolly hair (Naxos disease) maps to 17q21. Circulation 1998;97:2049-58.
80. McKoy G, Protonotarios N, Crosby A, Tsatsopoulou A, Anastasakis A, Coonar A, et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 2000;355:2119-24.
81. Whittock NV, Haftek M, Angoulvant N, Wolf F, Perrot H, Eady RA, et al. Genomic amplification of the human plakophilin 1 gene and detection of a new mutation in ectodermal dysplasia/skin fragility syndrome. J Invest Dermatol 2000;115:368-74.
82. McGrath JA, McMillan JR, Shemanko CS, Runswick SK, Leigh IM, Lane EB, et al. Mutations in the plakophilin 1 gene result in ectodermal dysplasia/skin fragility syndrome. Nat Genet 1997;17: 240-4.
83. North AJ, Bardsley WG, Hyam J, Bornslaeger EA, Cordingley HC, Trinnaman B, et al. Molecular map of the desmosomal plaque. J Cell Sci 1999;112:4325-36.
84. Hatzfeld M, Haffner C, Schulze K, Vinzens U. The function of plakophilin 1 in desmosome assembly and actin filament organization. J Cell Biol 2000;149:209-22.
85. Ruhrberg C, Williamson JA, Sheer D, Watt FM. Chromosomal localisation of the human envoplakin gene (EVPL) to the region of the tylosis oesophageal cancer gene (TOCG) on 17q25. Genomics 1996;37:381-5
86. Risk JM, Ruhrberg C, Hennies H, Mills HS, Di Colandrea T, Evans KE, et al. Envoplakin, a possible candidate gene for focal NEPPK/esophageal cancer (TOC): the integration of genetic and physical maps of the TOC region on 17q25. Genomics 1999;59:234-42.
87. Koch PJ, Mahoney MG, Ishikawa H, Pulkkinen L, Uitto J, Shultz L, et al. Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J Cell Biol 1997;137:1091-102.
88. Allen E, Yu QC, Fuchs E. Mice expressing a mutant desmosomal cadherin exhibit abnormalities in desmosomes, proliferation, and epidermal differentiation. J Cell Biol 1996;133:1367-82.
89. Bierkamp C, Mclaughlin KJ, Schwarz H, Huber O, Kemler R. Embryonic heart and skin defects in mice lacking plakoglobin. Dev Biol 1996;180:780-5.
90. Isac CM, Ruiz P, Pfitzmaier B, Haase H, Birchmeier W, Morano I. Plakoglobin is essential for myocardial compliance but dispensable for myofibril insertion into adherens junctions. J Cell Biochem 1999;72:8-15.
91. Bierkamp C, Schwarz H, Huber O, Kemler R. Desmosomal localization of beta-catenin in the skin of plakoglobin null-mutant mice. Development 1999;126:371-81.
92. Haftek M, Serre G, Mils V, Thivolet J. Immunocytochemical evidence for a possible role of cross-linked keratinocyte envelopes in stratum corneum cohesion. J Histochem Cytochem 1991;39: 1531-8.
93. Ruhrberg C, Hajibagheri MA, Simon M, Dooley TP, Watt FM. Envoplakin, a novel precursor of the cornified envelope that has homology to desmoplakin. J Cell Biol 1996;134:715-29.
94. Ruhrberg C, Hajibagheri MA, Parry DA, Watt FM. Periplakin, a novel component of cornified envelopes and desmosomes that belongs to the plakin family and forms complexes with envoplakin. J Cell Biol 1997;139:1835-49.
95. DiColandrea T, Karashima T, Maatta A, Watt FM. Subcellular distribution of envoplakin and periplakin: insights into their role as precursors of the epidermal cornified envelope. J Cell Biol 2000; 151:573-86.
96. Marekov LN, Steinert PM. Ceramides are bound to structural proteins of the human foreskin epidermal cornified cell envelope. J Biol Chem 1998;273:17763-70.
97. Ishida-Yamamoto A, Tanaka H, Nakane H, Takahashi H, Iizuka H. Antigen retrieval of loricrin epitopes at desmosomal areas of cornified cell envelopes: an immunoelectron microscopic analysis. Exp Dermatol 1999;8:402-6.
98. Maestrini E, Korge BP, Ocana-Sierra J, Calzolari E, Cambiaghi S, Scudder PM, et al. A missense mutation in connexin26, D66H, causes mutilating keratoderma with sensorineural deafness (Vohwinkel's syndrome) in three unrelated families. Hum Mol Genet 1999;8:1237-43.
99. Lefebvre PP, Van De Water TR. Connexins, hearing and deafness: clinical aspects of mutations in the connexin 26 gene. Brain Res Brain Res Rev 2000;32:159-62.
100. Richard G, White TW, Smith LE, Bailey RA, Compton JG, Paul DL, et al. Functional defects of Cx26 resulting from a heterozygous missense mutation in a family with dominant deaf-mutism and palmoplantar keratoderma. Hum Genet 1998;103:393-9.
101. Kelsell DP, Wilgoss AL, Richard G, Stevens HP, Munro CS, Leigh IM. Connexin mutations associated with palmoplantar keratoderma and profound deafness in a single family. Eur J Hum Genet 2000;8:141-4.
102. Mendes da Costa S. Erythro- et keratodermia variabilis in a mother and a daughter. Acta Derm Venereol 1925;6:255-61.
103. Richard G, Smith LE, Bailey RA, Itin P, Hohl D, Epstein EH, et al. Mutations in the human connexin gene GJB3 cause erythrokeratodermia variabilis. Nat Genet 1998;20:366-9.
104. Macari F, Landau M, Cousin P, Mevorah B, Brenner S, Panizzon R, et al. Mutation in the gene for connexin 30.3 in a family with erythrokeratodermia variabilis. Am J Hum Genet 2000;67:1296-301.
105. Hennemann H, Dahl E, White JB, Schwarz HJ, Lalley PA, Chang S, et al. Two gap junction genes, connexin 31.1 and 30.3, are closely linked on mouse chromosome 4 and preferentially expressed in skin. J Biol Chem 1992;267:17225-33.
106. Xia JH, Liu CY, Tang BS, Pan Q, Huang L, Dai HP, et al. Mutations in the gene encoding gap junction protein beta-3 associated with autosomal dominantly inherited hearing impairment. Nat Genet 1998;20:370-3.
107. Clouston HR. A hereditary ectodermal dystrophy. Can Med Assoc J 1929;21:18-31.
108. Lamartine J, Munhoz Essenfelder G, Kibar Z, Lanneluc I, Callouet E, Laoudj D, et al. Mutations in GJB6 cause hidrotic ectodermal dysplasia. Nat Genet 2000;26:142-4.
109. Kelsell DP, Dunlop J, Stevens HP, Lench NJ, Liang JN, Parry G, et al. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 1997;387:80-3.
110. Dahl E, Manthey D, Chen Y, Schwarz HJ, Chang YS, Lalley PA, et al. Molecular cloning and functional expression of mouse connexin-30, a gap junction gene highly expressed in adult brain and skin. J Biol Chem 1996;271:17903-10.
111. Plum A, Winterhager E, Pesch J, Lautermann J, Hallas G, Rosentreter B, et al. Connexin31-deficiency in mice causes transient placental dysmorphogenesis but does not impair hearing and skin differentiation. Dev Biol 2001;231:334-47.
112. Gutstein DE, Morley GE, Tamaddon H, Vaidya D, Schneider MD, Chen J, et al. Conduction slowing and sudden arrhythmic death in mice with cardiac-restricted inactivation of connexin43. Circ Res 2001;88:333-9.
113. Vaidya D, Tamaddon HS, Lo CW, Taffet SM, Delmar M, Morley GE, et al. Null mutation of connexin43 causes slow propagation of ventricular activation in the late stages of mouse embryonic development. Circ Res 2001;88:1196-202.
114. Willecke K, Kirchhoff S, Plum A, Temme A, Thonnissen E, Ott T. Biological functions of connexin genes revealed by human genetic defects, dominant negative approaches and targeted deletions in the mouse. Novartis Found Symp 1999;219:76-88.
115. Bilkle DD, Pillai S. Vitamin D, calcium, and epidermal differentiation. Endocr Rev 1993;14:3-19.
116. Richaed G. Connexins: a connection with the skin. Exp Dermatol 2000;9:77-96.
117. Labarthe MP, Bosco D, Saurat JH, Meda P, Salomon D. Upregulation of connexin 26 between keratinocytes of psoriatic lesions. J Invest Dermatol 1998;111:72-6.
118. Lucke T, Choudhry R, Thom R, Selmer IS, Burden AD, Hodgins MB. Upregulation of connexin 26 is a feature of keratinocyte differentiation in hyperproliferative epidermis, vaginal epithelium, and buccal epithelium. J Invest Dermatol 1999;112:354-61.
119. Masgrau-Peya E, Salomon D, Saurat JH, Meda P. In vivo modulation of connexins 43 and 26 of human epidermis by topical retinoic acid treatment. J Histochem Cytochem 1997;45:1207-15.
120. Brissette JL, Kumar NM, Gilula NB, Hall JE, Dotto GP. Switch in gap junction protein expression is associated with selective changes in junctional permeability during keratinocyte differentiation. Proc Natl Acad Sci U S A 1994;91:6453-7.
121. Jorgensen NR, Henriksen Z, Brot C, Eriksen EF, Sorensen OH, Civitelli R, et al. Human osteoblastic cells propagate intercellular calcium signals by two different mechanisms. J Bone Miner Res 2000;15:1024-32.
122. Hofer T, Politi A, Heinrich R. Intercellular Ca2+ wave propagation through gap-junctional Ca2+ diffusion: a theoretical study. Biophys J 2001;80:75-87.
123. Charles AC, Kodali SK, Tyndale RF. Intercellular calcium waves in neurons. Mol Cell Neurosci 1996;7:337-53.
124. D'Andrea P, Calabrese A, Capozzi I, Grandolfo M, Tonon R, Vittur F. Intercellular Ca2+ waves in mechanically stimulated articular chondrocytes. Biorheology 2000;37:75-83.
125. Yada Y, Ozeki T, Meguro S, Mori S, Nozawa Y. Signal transduction in the onset of terminal keratinocyte differentiation induced by 1 alpha, 25-dihydroxyvitamin D3: role of protein kinase C translocation. Biochem Biophys Res Commun 1989;163: 1517-22.
126. Resing KA, al-Alawi N, Blomquist C, Fleckman P, Dale BA. Independent regulation of two cytoplasmic processing stages of the intermediate filament-associated protein filaggrin and role of Ca2+ in the second stage. J Biol Chem 1993;268:25139-45.
127. Li L, Tucker RW, Hennings H, Yuspa SH. Chelation of intracellular Ca2+ inhibits murine keratinocyte differentiation in vitro. J Cell Physiol 1995;163:105-14.
128. Li L, Tucker RW, Hennings H, Yuspa SH. Inhibitors of the intracellular Ca(2+)-ATPase in cultured mouse keratinocytes reveal components of terminal differentiation that are regulated by distinct intracellular Ca2+ compartments. Cell Growth Differ 1995;6:1171-84.
129. Turk B, Turk V, Turk D. Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors. Biol Chem 1997;378:141-50.
130. Paris A, Strukelj B, Pungercar J, Renko M, Dolenc I, Turk V. Molecular cloning and sequence analysis of human preprocathepsin C. FEBS Lett 1995;369:326-30.
131. Toomes C, James J, Wood AJ, Wu CL, McCormick D, Lench N, et al. Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet 1999;23:421-4.
132. Hart TC, Hart PS, Bowden DW, Michalec MD, Callison SA, Walker SJ, et al. Mutations of the cathepsin C gene are responsible for Papillon-Lef@vre syndrome. J Med Genet 1999;36:881-7.
133. Hart PS, Zhang Y, Firatli E, Uygur C, Lotfazar M, Michalec MD, et al. Identification of cathepsin C mutations in ethnically diverse Papillon-Lefèvre syndrome patients. J Med Genet 2000;37:927-32.
134. Hart TC, Hart PS, Michalec MD, Zhang Y, Firatli E, Van Dyke TE, et al. Haim-Munk syndrome and Papillon-Lefèvre syndrome are allelic mutations in cathepsin C. J Med Genet 2000;37:88-94.
135. Rao NV, Rao GV, Hoidal JR. Human dipeptidyl-peptidase I. Gene characterization, localization, and expression. J Biol Chem 1997;272:10260-5.
136. Mier PD, van den Hurk JJ. Lysosomal hydrolases of the epidermis. 3. Peptide hydrolases. Br J Dermatol 1975;93:509-17.
137. Rowden G. Ultrastructural studies of keratinized epithelia of the mouse. IV. Quantitative studies of lysosomes. J Invest Dermatol 1975;64:4-8.
138. Kawada A, Hara K, Morimoto K, Hiruma M, Ishibashi A. Rat epidermal cathepsin B: purification and characterization of proteolytic properties toward filaggrin and synthetic substrates. Int J Biochem Cell Biol 1995;27:175-83.
139. Kawada A, Hara K, Hiruma M, Noguchi H, Ishibashi A. Rat epidermal cathepsin L-like proteinase: purification and some hydrolytic properties toward filaggrin and synthetic substrates. J Biochem (Tokyo) 1995;118:332-7.
140. Horikoshi T, Igarashi S, Uchiwa H, Brysk H, Brysk MM. Role of endogenous cathepsin D-like and chymotrypsin-like proteolysis in human epidermal desquamation. Br J Dermatol 1999; 141:453-9.
141. Fischer J, Bouadjar B, Heilig R, Huber M, Lefèvre C, Jobard F, et al. Mutations in the gene encoding SLURP-1 in Mal de Meleda. Hum Mol Genet 2001;10:875-80.
142. Reid FM, Vernham GA, Jacobs HT. A novel mitochondrial point mutation in a maternal pedigree with sensorineural deafness. Hum Mutat 1994;3:243-7.
143. Fischel-Ghodsian N, Prezant TR, Fournier P, Stewart IA, Maw M. Mitochondrial mutation associated with nonsyndromic deafness. Am J Otolaryngol 1995;16:403-8.
144. Sevior KB, Hatamochi A, Stewart IA, Bykhovskaya Y, Allen-Powell DR, Fischel-Ghodsian N, et al. Mitochondrial A7445G mutation in two pedigrees with palmoplantar keratoderma and deafness. Am J Med Genet 1998;75:179-85.
145. Hutchin TP, Lench NJ, Arbuzova S, Markham AF, Mueller RF. Maternally inherited hearing impairment in a family with the mitochondrial DNA A7445G mutation. Eur J Hum Genet 2001; 9:56-8.
146. Bohnert A, Anton-Lamprecht I. Richner-Hanhart's syndrome: ultrastructural abnormalities of epidermal keratinization indicating a causal relationship to high intracellular tyrosine levels. J Invest Dermatol 1982;79:68-74.
147. El-Shoura SM, Tallab TM. Richner-Hanhart's syndrome: new ultrastructural observations on skin lesions of two cases. Ultrastruct Pathol 1997;21:51-6.